Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus

• Κύριοι συγγραφείς: Constantine E Kosmas (Συγγραφέας), Delia Silverio (Συγγραφέας), Andreas Sourlas (Συγγραφέας), Frank Garcia (Συγγραφέας), Peter D Montan (Συγγραφέας), Eliscer Guzman (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BioExcel Publishing Ltd, 2018-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Lipid-lowering therapy is used very commonly nowadays not only for the optimization of the lipid profile but also to reduce cardiovascular risk. However, some studies have linked the use of certain lipid-lowering agents with an increased risk for impaired glycemic control and new-onset diabetes mell...